Title |
Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)
|
---|---|
Published in |
Drugs - Real World Outcomes, November 2019
|
DOI | 10.1007/s40801-019-00165-8 |
Pubmed ID | |
Authors |
Adam M. Bressler, Ali A. Hassoun, Louis D. Saravolatz, Valerie Ravenna, Chris N. Barnes, Bibiana Castaneda-Ruiz |
Mendeley readers
The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 17 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 4 | 24% |
Student > Bachelor | 3 | 18% |
Student > Doctoral Student | 2 | 12% |
Researcher | 2 | 12% |
Lecturer | 1 | 6% |
Other | 1 | 6% |
Unknown | 4 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 7 | 41% |
Veterinary Science and Veterinary Medicine | 1 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
Environmental Science | 1 | 6% |
Nursing and Health Professions | 1 | 6% |
Other | 1 | 6% |
Unknown | 5 | 29% |